Tag: endocrinology

Obesity Amplifies Harmful Effects of Alcohol on the Liver

Being overweight or having obesity significantly increases the risk for liver disease and the likelihood of dying from it compared with being of normal weight, regardless...

FDA Approves ‘Gamechanger’ Semaglutide for Weight Loss

The US Food and Drug Administration (FDA) has approved a 2.4 mg/week subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...

First AACE Guidelines on Diabetes Technology

The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with...

Any Bone Break Increases Risk for Subsequent Fracture in Older Women

No matter where an initial fracture occurs in a postmenopausal woman, there is a subsequent increased risk of another fracture, with the risk surprisingly highest...

FDA Blazes Path for ‘Real-World’ Evidence as Proof of Efficacy

In 2016, results from the LEADER trial of liraglutide in patients with type 2 diabetes helped jumpstart awareness of the potential role of this new...

Most Kids With Type 1 Diabetes and COVID-19 in US Fared Well

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The majority of children with type 1 diabetes who tested positive...

Promising Data on Once-Weekly Insulin, Phase 3 Study Ongoing

Two new phase 2 studies show encouraging findings with the investigational once-weekly basal insulin analogue icodec (Novo Nordisk) for people with type 2 diabetes who...

Wearable Continuous Ketone Monitoring Appears Feasible

Continuous measurement of ketone levels with a wearable device is feasible, new research suggests. A small sensing device worn on the upper arm, similar to...

Eating More Fat May Boost Borderline Low Testosterone

“Low-fat diets appear to decrease testosterone levels in men, but further randomized controlled trials are needed to confirm this effect,” the authors of a meta-analysis...

Type 1 Diabetes and Transgender Identity: Is There a Link?

The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general population, research suggests. This has been reported...

Endocrinologist Charged After Bomb-Making Supplies Found

An endocrinologist in Naples, Florida, faces multiple federal charges after police found homemade explosives and bomb-making supplies, as well as numerous illegal drugs, in his...

Increase in Thyroid Cancer Rates Points to Overscreening

The incidence of thyroid cancer cases has increased markedly since the late 1990s, although rates vary widely between countries, and the increases have been largely...

Eating Fish Links With Fewer CVD Events in High-Risk People

People with cardiovascular disease (CVD) who regularly ate fish had significantly fewer major CVD events and there were fewer total deaths compared with similar individuals...

2021 NRMP Specialty Match Sees Record Numbers

The number of applicants to the Specialties Matching Service (SMS) of the National Resident Matching Program (NRMP) continued to grow this year, as did the...

Contrary to Popular Belief, Insulin Can Be Stored Outside Fridge

Insulin may be more heat-stable during 28 days of use than current labeling suggests, a new study indicates. Instructions on insulin vials or pens indicate...

Large Study Finds Trans Men on Testosterone at Risk for Blood Clots

Over 10% of transgender men (females transitioning to male) who take testosterone develop high hematocrit levels that could put them at greater risk for a...

Semaglutide for Weight Loss? A Good First STEP, With Caveats

The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named,...

What’s the Best Second-Line Drug Class for Type 2 Diabetes?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes appear to confer greater cardiovascular benefit than glucagon-like peptide-1 (GLP-1) receptor agonists among older adults...

COVID-19 Drives Physician Burnout for Some Specialties

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Physician burnout remains at a critical level, at 42% overall ―...

Endocrine Society Call for Action to Reduce Insulin Costs in US

The Endocrine Society has issued a new position statement calling on all stakeholders, including clinicians, to play a role in reducing the cost of insulin...

New Developments in Thyroid Cancer

In a widely publicized story from 2020, a Florida news reporter discovered she had thyroid cancer after a viewer sent her a concerned email about a lump on her...

Surgery Equals Drug Tx for Bleeding in Diabetic Retinopathy

In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy...

Type 1 Diabetes Screen Costing $55 Is Launched in US

A new initiative launched by the diabetes charity JDRF aims to broaden screening for type 1 diabetes risk for the general population of the United...

Bariatric Surgery Might Reduce Severity of COVID-19 Infection

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. People with obesity who lost weight as a result of bariatric...

Temper Enthusiasm for Long-term Treatment With Bisphosphonates?

Women treated with oral bisphosphonate drugs for osteoporosis for 5 years get no additional benefit ― in terms of hip fracture risk ― if the...